# Experimental Medication For the Treatment of Generalized Anxiety Disorder

> **NCT00097708** · PHASE3 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 511 (actual)

## Conditions studied

- Anxiety Disorder

## Interventions

- **DRUG:** experimental anti-anxiety drug

## Key facts

- **NCT ID:** NCT00097708
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 511 (ACTUAL)
- **Last updated:** 2014-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00097708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00097708, "Experimental Medication For the Treatment of Generalized Anxiety Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00097708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*